Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
78%
OVERLAP
BY WEIGHT
34
# OF OVERLAPPING
HOLDINGS
ESIH.L
49
HOLDINGS
97%
ALSO IN EXV4.DE
EXV4.DE
60
HOLDINGS
81%
ALSO IN ESIH.L
SECTOR DRIFT (ESIH.L minus EXV4.DE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in ESIH.L |
Weight in EXV4.DE |
Overlap | |
|---|---|---|---|---|
 |
ASTRAZENECA PLC | 15.5% | 15.1% | 15.1% |
 |
NOVARTIS AG | 15.4% | 14.4% | 14.4% |
 |
NOVO NORDISK A/S-B | 8.0% | 7.8% | 7.8% |
|
GSK PLC | 5.7% | 5.5% | 5.5% |
 |
SANOFI-AVENTIS | 5.3% | 5.4% | 5.3% |
ESIH.L Overweight Relative to EXV4.DE
|
NOVARTIS AG | 1.0% |
|
ROCHE HOLDING AG-BR | 0.7% |
|
ASTRAZENECA PLC | 0.4% |
|
NOVO NORDISK A/S-B | 0.2% |
|
GSK PLC | 0.1% |
 |
UCB SA | 0.1% |
 |
FRESENIUS MEDICAL CARE AG & | 0.1% |
 |
ARGEN-X SE | 0.1% |
|
BAYER AG | 0.1% |
|
LONZA GROUP AG-REG | 0.1% |
ESIH.L Underweight Relative to EXV4.DE
|
NOVOZYMES A/S-B SHARES | -1.2% |
|
CONVATEC GROUP PLC | -0.3% |
 |
GETINGE AB-B SHS | -0.3% |
|
ZEALAND PHARMA A/S | -0.2% |
|
HIKMA PHARMACEUTICALS PLC | -0.2% |
|
BAVARIAN NORDIC A/S | -0.1% |
|
CAMURUS AB | -0.1% |
|
AMBU A/S CLASS B | -0.1% |
|
SWEDISH ORPHAN BIOVITRUM AB | -0.1% |
|
COLOPLAST A/S CLASS B | -0.1% |